Formulation Excipient Compatibility

Formulation excipient compatibility assessment confirms inactive ingredients do not interact chemically or physically with active pharmaceuticals. Thermal stress testing at elevated temperatures accelerates degradation revealing incompatibilities. Headspace analysis detects volatile degradation products. Mass spectrometry identifies reaction byproducts. Chemical mechanisms underlying incompatibilities guide reformulation.

Incompatible excipients compromise product stability requiring alternative selections. Formulation buffering and chelation minimise reactive intermediates preventing degradation. Container-closure selections account for excipient interactions with packaging. Regulatory submissions justify excipient selections demonstrating compatibility. Post-approval manufacturing changes require compatibility re-evaluation.